ITCI

Intra-Cellular Therapies Inc.

Delisted

ITCI was delisted on the 1st of April, 2025.

131 hedge funds and large institutions have $692M invested in Intra-Cellular Therapies Inc. in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 51 increasing their positions, 44 reducing their positions, and 13 closing their positions.

Holders
131
Holders Change
Holders Change %
0%
% of All Funds
3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
51
Reduced
44
Closed
13
Calls
$35.4M
Puts
$20.5M
Net Calls
+$14.8M
Net Calls Change
+$5M
Name Market Value Shares Shares
Change
Shares
Change %
DBT
126
Dubuque Bank & Trust
Iowa
$4K 250
LTFS
127
Ladenburg Thalmann Financial Services
Florida
$3K 150
EMG
128
ETF Managers Group
New Jersey
$2.13K 23,879 +114 +0.5%
Federated Hermes
129
Federated Hermes
Pennsylvania
$1K 27 -89,716 -100%
QT
130
Quantbot Technologies
New York
$1K 82 -5,616 -99%
HMS
131
Hanseatic Management Services
New Mexico
$1K 42
PP
132
PDT Partners
New York
-115,700 Closed
Two Sigma Investments
133
Two Sigma Investments
New York
-96,274 Closed
PA
134
Perceptive Advisors
New York
-70,000 Closed
EGM
135
Engineers Gate Manager
New York
-66,308 Closed
OAM
136
Oxford Asset Management
United Kingdom
-52,363 Closed
RA
137
Royce & Associates
New York
-30,000 Closed
PAM
138
Premier Asset Management
Illinois
-19,088 Closed
VF
139
Virtu Financial
New York
-18,538 Closed
BFM
140
Boothbay Fund Management
New York
-11,300 Closed
CIBC Private Wealth Group
141
CIBC Private Wealth Group
Georgia
-10,200 Closed
Teacher Retirement System of Texas
142
Teacher Retirement System of Texas
Texas
-9,628 Closed
CMBA
143
C.M. Bidwell & Associates
Hawaii
-3,815 Closed
SWP
144
Stratos Wealth Partners
Ohio
-33 Closed
DAM
145
DLD Asset Management
New York
WVP
146
Worth Venture Partners
New Jersey